RGP vs TBI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 11, 2026

RGP

39.0
AI Score
VS
TBI Wins

TBI

45.7
AI Score

Investment Advisor Scores

RGP

39score
Recommendation
SELL

TBI

46score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric RGP TBI Winner
Forward P/E 11.9617 10.6724 TBI
PEG Ratio 0.7976 0.7622 TBI
Revenue Growth -23.8% 11.8% TBI
Earnings Growth -10.9% -63.4% RGP
Tradestie Score 39.0/100 45.7/100 TBI
Profit Margin -9.0% -3.4% TBI
Beta 1.00 1.00 Tie
AI Recommendation SELL HOLD TBI

Relative Price Performance (Last 90 Days)

RGP 1M: -4.8% · 3M: -15.0% TBI 1M: -11.8% · 3M: +27.4%

Current Technical Phase

RGP

Markdown
Sell / avoid

Price below a falling SMA50 (slope -1.6%), weak momentum, RSI 41

RSI (14): 41.4 · Price: $3.97

TBI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 37

RSI (14): 36.6 · Price: $8.75

Fundamentals Snapshot

Metric RGP TBI
Market Cap
Forward P/E -397.0 10.7
Trailing P/E
Revenue (TTM)
Revenue Growth -0.2% 0.1%
Gross Margin 0.4% 0.2%
Operating Margin -0.1% 0.0%
EPS -1.22 -1.88
Dividend Yield 0.07%

Frequently Asked Questions

Based on our detailed analysis, TBI is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.